Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab Extension Study in Solid Tumors
NCT01588184Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2012
- Primary completion
- Sep 2019
- Modality
- Monoclonal Antibodies
- Countries
- 21
01
Overview
A Phase 4 trial of bevacizumab in breast cancer, ovarian cancer, primary peritoneal carcinoma (PPC), renal cell carcinoma (RCC), colorectal cancer (CRC), sponsored by Roche. Started Jul 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancerovarian cancerprimary peritoneal carcinoma (PPC)renal cell carcinoma (RCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01588184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588184.